Are antibodies directed against amyloid-β (Aβ) oligomers the last call for the Aβ hypothesis of Alzheimer's disease?

Autor:	Davide Seripa, Francesco Panza, Madia Lozupone, Antonio Greco, Giancarlo Logroscino, Vittorio Dibello, Bruno P. Imbimbo, Antonio Daniele
Rok vydání:	2019
Předmět:	Amyloid β medicine.drug_class Immunology passive immunotherapy Disease prodromal Alzheimer's disease Monoclonal antibody Antibodies Monoclonal Humanized aducanumab Alzheimer's disease BAN2401 dementia MCI monoclonal antibodies Immunology and Allergy Oncology Alzheimer Disease medicine Dementia Animals Aspartic Acid Endopeptidases Humans Clinical Trials as Topic Amyloid beta-Peptides biology business.industry Aβ oligomers Brain medicine.disease Protein multimerization Settore MED/26 - NEUROLOGIA Neuroprotective Agents biology.protein Aducanumab Immunotherapy Antibody Amyloid Precursor Protein Secretases Protein Multimerization business Peptides
Zdroj:	Immunotherapy. 11(1)
ISSN:	1750-7448
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0355b7f28eaff11f3aa1fbd4a50fa6bf https://pubmed.ncbi.nlm.nih.gov/30702009 Zobrazit plný text záznamu